News

The Office of Public Affairs (OPA) coordinates the Board’s communication activities including media relations, social media, Public Records Act (PRA) requests, and the Board’s quarterly newsletter.

Latest News

The Medical Board of California (Board) has temporarily suspended the ability for licensees to renew early if their license expires after December 31, 2021. Pending legislation, Senate Bill (SB) 806, includes multiple changes to the Board’s licensing fees that, if approved, would take effect January 1, 2022.

If signed into law, the Board will release additional information on its website as soon as possible regarding the new fee amounts, the timing of when licenses may be renewed, and other aspects of the bill that impact the public, applicants, and licensees. In the meantime, information on the bill may be accessed on the California Legislative Information Website.

The Statewide Overdose Safety (SOS) Workgroup has issued some best practices for physicians and surgeons who may have inherited patients on opioid medications due to the recent, abrupt closures of 29 California pain management centers in May 2021. The closure of the centers resulted in over 20,000 patients without referrals, medical records, or treatment plans, and created a potentially dangerous disruption in the care for patients receiving treatment with opioid therapy.

The Medical Board of California (Board) would like to inform you of a change in the United States Medical Licensing Examination’s (USMLE) policy regarding test attempts.

Beginning July 1, 2021, the USMLE’s attempt limit policy will be reduced from six attempts to four attempts per Step exam.

The USMLE Composite Committee, the governing body of USMLE, voted to change the number of allowed attempts to protect the integrity of the exam and to more closely match the USMLE attempt limits imposed by the majority of state medical boards.

For more information about the USMLE’s change in its attempt limit policy, visit the FAQs on the USMLE’s website. If you have questions about how this change impacts you, please email the Office of the USMLE Secretariat at USMLESec@nbme.org.

The Medical Board of California (Board) would like to inform you that the fee charged to maintain the Controlled Substances Utilization Review and Evaluation System (CURES) is set to increase.

Contact Us

Media Inquiries

Carlos Villatoro

Public Information Manager

Carlos.Villatoro@mbc.ca.gov

(916) 263-2394

Newsletter & Story Ideas

Emmalee Ross

Public Information Officer

Emmalee.Ross@mbc.ca.gov

(916) 263-2480

PRA Requests

Alexandria Schembra

Associate Program Analyst

Alexandria.Schembra@mbc.ca.gov

(916) 263-2466

Recent Tweets


Tweets by MedBoardOfCA